Status:

RECRUITING

Effects of Pericapsular Nerve Group Block Applied in Patients Undergoing Hip Fracture Surgery.

Lead Sponsor:

Umraniye Education and Research Hospital

Conditions:

Hip Fractures

Pain, Postoperative

Eligibility:

All Genders

30-85 years

Phase:

NA

Brief Summary

In this study, it was aimed to compare the multimodal analgesia application or the pericapsular nerve group (PENG) block methods in patients undergoing hip surgery. The effectiveness and benefit rate ...

Detailed Description

This prospective randomised controlled study included a total of 70 patients aged 30-85 years who underwent hip fracture surgery under spinal anaesthesia. Patients were randomly divided into two group...

Eligibility Criteria

Inclusion

  • Patients who will undergo hip fracture surgery Women and men aged 30-85

Exclusion

  • Patients under 30 years old, over 85 years old
  • American Society of Anesthesiology (ASA) IV,
  • Those with cognitive impairment (alzheimer, dementia, delirium, etc.)
  • Those with application site infection
  • Those who are allergic to local anesthetic substances
  • Patients are non-consenting patients.

Key Trial Info

Start Date :

November 21 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 30 2026

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT06183541

Start Date

November 21 2023

End Date

January 30 2026

Last Update

November 19 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Umraniye Education and Research Hospital

Istanbul, Umraniye, Turkey (Türkiye), 34734

2

UmraniyeERH

Istanbul, Umraniye, Turkey (Türkiye), 34734

Effects of Pericapsular Nerve Group Block Applied in Patients Undergoing Hip Fracture Surgery. | DecenTrialz